Environmental & Economic Factors Drives Global Demand for Pharmaceutical
leak Testing and Deblistering
Global packaging specialist,Sepha, says the increased pressure to reduce costs and waste is
driving global pharma-industry demand for its range of deblistering and blister-scanning
technologies. While blisterpacks offer pharmaceutical companies a simple and secure way of
providing pharmaceuticals to consumers, their robust design often makes it difficult to either test
for leaks or recover product from rejected packages on an industrial scale, generating
considerable waste. This waste can have significant impact on production yields and waste
reduction targets, and therefore also manufacturing costs. But the range of technology from the
Northern Ireland manufacturer Sepha is helping to solve the problem.
Belfast (Vocus) -- Global packaging specialist, Sepha, says the increased pressure to reduce costs and waste is
driving global pharma-industry demand for its range of deblistering and blister-scanning technologies. While
blisterpacks offer pharmaceutical companies a simple and secure way of providing pharmaceuticals to consumers,
their robust design often makes it difficult to either test for leaks or recover product from rejected packages on an
industrial scale, generating considerable waste. This waste can have significant impact on production yields and
waste reduction targets, and therefore also manufacturing costs. But the range of technology from the Northern
Ireland manufacturer Sepha is helping to solve the problem.
Pharmaceutical leak testing and deblistering technology from the Northern Ireland manufacturer, Sepha, is
helping to solve the problem of reducing pharmaceutical waste and manufacturing costs during tough economic
times. Their machines such as Press-Out Universal, can recover drugs from rejected packs at a rate of up to 50
tablets and capsules per minute, transforming a laborious task traditionally done by hand into an automated
process. Whilst Sepha’s innovative pharmaceutical leak